These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7241410)

  • 21. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III.
    Aoki Y; Ohishi R; Takei R; Matsuzaki O; Mohri M; Saitoh K; Gomi K; Sugihara T; Kiyota T; Yamamoto S
    Thromb Haemost; 1994 Apr; 71(4):452-5. PubMed ID: 8052962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disseminated intravascular coagulation: an update.
    Hardaway RM; Williams CH
    Compr Ther; 1996 Nov; 22(11):737-43. PubMed ID: 8978981
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prophylaxis of consumption coagulopathy in shock. Dependence of the effect of heparin on the activity of antithrombin III (author's transl)].
    Bergmann H; Blauhut B; Necek S; Kramar H; Vinazzer H
    Anaesthesist; 1980 Nov; 29(11):623-6. PubMed ID: 7457802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Microcirculation, degree of toxemia and the function of the reticuloendothelial system in experimental traumatic shock in rats].
    Shtykhno IuM; Nedoshivina RV
    Patol Fiziol Eksp Ter; 1977; (4):36-9. PubMed ID: 927898
    [No Abstract]   [Full Text] [Related]  

  • 25. A combination of a thrombin inhibitor and dexamethasone prevents the development of experimental disseminated intravascular coagulation in rats.
    Elg M; Gustafsson D
    Thromb Res; 2006; 117(4):429-37. PubMed ID: 15869787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Respiratory insufficiency in shock complicated by disseminated intravascular coagulation (summary of the thesis)].
    Jastrzebski J
    Acta Haematol Pol; 1981; 12(2):113-21. PubMed ID: 7304088
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of phagocyte stimulation on the nonspecific resistance of the body to shock].
    Kharin GM; Shakirova AZ; Sabitova AM
    Biull Eksp Biol Med; 1998 Nov; 126(11):548-51. PubMed ID: 9883366
    [No Abstract]   [Full Text] [Related]  

  • 28. [Use of heparin in the early post-traumatic period in burns and hemorrhage].
    Kil'diushov AN
    Anesteziol Reanimatol; 1994; (5):26-8. PubMed ID: 7893070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Long-term treatment with low molecular weight heparin, of chronic disseminated intravascular coagulation].
    García Fernández JR; López Berenguel F; Ais C
    An Med Interna; 2003 Apr; 20(4):191-4. PubMed ID: 12768833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coagulation activation by MC28 fibrosarcoma cells facilitates lung tumor formation.
    Amirkhosravi M; Francis JL
    Thromb Haemost; 1995 Jan; 73(1):59-65. PubMed ID: 7740497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ultrastructural appearance of intravascular coagulation in the kidney caused by burn injury].
    Saakov BA; Bardakhch'ian EA; Bochkov NI
    Biull Eksp Biol Med; 1981 Nov; 92(11):609-12. PubMed ID: 7317645
    [No Abstract]   [Full Text] [Related]  

  • 32. High prevalence of antiphospholipid antibodies in disseminated intravascular coagulation.
    Karmochkine M; Mazoyer E; Marcelli A; Boffa MC; Piette JC
    Thromb Haemost; 1996 Jun; 75(6):971. PubMed ID: 8822595
    [No Abstract]   [Full Text] [Related]  

  • 33. [Acute disseminated intravascular coagulation caused by heparin therapy].
    Bozóky G; Varga J; Biliczki F
    Orv Hetil; 1981 Jun; 122(23):1399-400. PubMed ID: 7279412
    [No Abstract]   [Full Text] [Related]  

  • 34. [Serum complement components in patients with leukemia with special reference to disseminated intravascular coagulation (DIC) (author's transl)].
    Ishizaki T; Hashizume K; Kometani M; Tanaki T; Numata T; Oba N; Matsubara F; Tsukuda K; Hattori K
    Rinsho Ketsueki; 1980 Feb; 21(2):169-78. PubMed ID: 7411863
    [No Abstract]   [Full Text] [Related]  

  • 35. Variability in the degree of opsonization and phagocytosis of strains of Staphylococcus aureus isolated from patients with disseminated intravascular coagulation.
    Tuazon CU; Sheagren JN; Quie PG
    J Lab Clin Med; 1981 Dec; 98(6):949-55. PubMed ID: 7310231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The treatment with low-molecular-weight heparin of disseminated intravascular coagulation secondary to an aortic aneurysm].
    Callejas Rubio JL; Ortego Centeno N; Díez Ruiz A; Bermúdez García JM
    Rev Clin Esp; 1998 Nov; 198(11):781-2. PubMed ID: 9883061
    [No Abstract]   [Full Text] [Related]  

  • 37. [Relationship between changes in factors of nonspecific resistance during traumatic and burn shock].
    Kharin GM; Sabitova AM
    Biull Eksp Biol Med; 1997 May; 123(5):541-4. PubMed ID: 9264707
    [No Abstract]   [Full Text] [Related]  

  • 38. Fibrinopeptide A in liver cirrhosis: evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver disease.
    Mombelli G; Fiori G; Monotti R; Haeberli A; Straub PW
    J Lab Clin Med; 1993 Jan; 121(1):83-90. PubMed ID: 8426084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current management of disseminated intravascular coagulation.
    Wheeler A; Rubenstein EB
    Oncology (Williston Park); 1994 Sep; 8(9):69-73; discussion 73-6, 79. PubMed ID: 7993725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of low molecular weight heparin in a canine model of thromboplastin-induced acute disseminated intravascular coagulation.
    Mischke R; Fehr M; Nolte I
    Res Vet Sci; 2005 Aug; 79(1):69-76. PubMed ID: 15894027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.